Courageous and great article from @MSKCancerCenter on Histotripsy published in @cvironco ! Link: link.springer.com/article/10… “Patients arrive with predetermined expectations shaped by marketing rather than clinical reality, pressuring physicians to offer treatments lacking comprehensive validation. Healthcare institutions acquire expensive systems to remain competitive, even when clinical need may not justify the investment. Resources are diverted toward technologies with limited proven benefit, while established treatments receive diminished attention.” “Aggressive promotion, driven by commercial interests and capital market pressures, presents theoretical benefits as established advantages. Current histotripsy studies remain predominantly single-center experiences with limited follow-up. The technology’s purported immunologic effects remain entirely theoretical, yet marketing materials present these claims with inappropriate certainty. Patients seek "non-invasive" treatments based on promotional materials overstating capabilities while minimising limitations. This marketing-first approach raises ethical concerns about informed consent and resource allocation.”

If you have a MSc degree in Biomedical Engineering, EE, or Computer Science, have experience with Medical Image Analysis and are proficient with Python, MATLAB, PyTorch, TensorFlow, C/C++ and would like to join a lab for 1-2 years to work on liver cancer, please DM/email.